Morgan Stanley’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Morgan Stanley’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-161,676	Closed	-$6.67M	–	6969
2015 Q2	$6.67M	Buy	161,676 +112,448	+228%	+$4.03M	﹤0.01%	2535
2015 Q1	$1.73M	Sell	49,228 -110,891	-69%	-$3.75M	﹤0.01%	3710
2014 Q4	$5.14M	Buy	160,119 +18,391	+13%	+$532K	﹤0.01%	2712
2014 Q3	$3.98M	Buy	141,728 +67,950	+92%	+$2.07M	﹤0.01%	2832
2014 Q2	$2.23M	Buy	73,778 +19,356	+36%	+$534K	﹤0.01%	3406
2014 Q1	$1.51M	Buy	54,422 +14,313	+36%	+$375K	﹤0.01%	3671
2013 Q4	$1.02M	Sell	40,109 -1,169	-3%	-$36K	﹤0.01%	3923
2013 Q3	$1.23M	Sell	41,278 -14,345	-26%	-$399K	﹤0.01%	3616
2013 Q2	$1.6M	Buy	+55,623	New	+$1.53M	﹤0.01%	3337

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Morgan Stanley's BRLI Position: Q3 2015 in Review

Morgan Stanley sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 161,676 shares — an estimated $6.67M sold.

Morgan Stanley first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $6.67M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Morgan Stanley reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Morgan Stanley sold 161,676 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $6.67M.
Morgan Stanley first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Morgan Stanley's BIO-REFERENCE LABS INC-NEW- position peaked at $6.67M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Morgan Stanley's 13F filing for Q3 2015, filed 9 Nov 2015.